Peptonic Medical

"This is an important step to increase the attractiveness of our portfolio in the eyes of consumers and distribution partners in the US", says Erik Sundquist, CEO of Peptonic Medical

The global intimate cleanser market is ca 1.2 billion USD growing at an annual rate of ca 3,5%. Somewhat simplified the market constitutes of soaps and oils. With soaps there is a risk of disturbing the vaginal microflora possibly leading to dryness and vaginal infections, with oils there is a challenge to cleanse water soluble impurities. Peptonics intimate cleanser is positioned in between. Based on the company's clinically proven vaginal gel and a Nordic botanical oil VagiVital Moisturizing V Cleanser allows cleansing of both water and oil soluble impurities without disturbing the microflora. In parallel Peptonics patented cleanser moisturizes the intimate area and it is recommended by gynecologists.

"The intimate cleanser is an important part of our diagnose, treat and prevent concept. As it moisturizes at the same time it cleanses without disturbing the vaginal microflora it works preventively. The patent approval will allow us to further differentiate our offer in the market", says Erik Sundquist